Maia Biotechnology, Inc.
THIO, a small molecule therapeutic targeting telomerase-dependent cancer cells in non-small cell lung cancer
- Sector
- Biotech
- Headquarters
- IL
- Latest Form D
- $1.5M, Jan 2026
- Total capital
- $20.3M
- Federal grants
- $770K
- 1 award · 2025
- Rank in peer group#162 of 326
- Private capital raised
- $19.6M
- 7 Form D · last Jan 2026
- 10 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 0
- 10 pending
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 7th filing$1.5M
- Private capital raisedForm D · SEC · 6th filing$3M
- Federal grantHealth and Human S · Phase II · Novel Telomere-Targeting Therapy for Advanced Non-Small Cell Lung Cancer$770K
- Private capital raisedForm D · SEC · 5th filing$695K
- Private capital raisedForm D · SEC · 4th filing$4.1M
- Private capital raisedForm D · SEC · 3rd filing$2.4M
- Private capital raisedForm D · SEC · 2nd filing$2.9M
- Private capital raisedForm D · SEC · 1st filing$4.9M
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 326 peers
Line = medianBiotech · Molecule
- Federal grants#162 · top 50%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
From SEC Form D filings- Cristian Yee LuputDirectorNamed in SEC Form D filings
- Jean-Manasse TheageneDirectorNamed in SEC Form D filings
- Jeffrey C HimmelreichExecutive OfficerNamed in SEC Form D filings
- Louie Ngar YeeDirectorNamed in SEC Form D filings
- Louie Ngar YeeDirectorNamed in SEC Form D filings
- Ngar Yee LouieDirectorNamed in SEC Form D filings
Show all 12 people
- Ngar Yee V. LouieDirectorNamed in SEC Form D filings
- Ramiro GuerreroDirectorNamed in SEC Form D filings
- Sergei M GryaznovExecutive OfficerNamed in SEC Form D filings
- Stan SmithDirectorNamed in SEC Form D filings
- Steven ChaoukiDirectorNamed in SEC Form D filings
- Vlad VitocExecutive Officer, DirectorNamed in SEC Form D filings
What it has protected
USPTO · 0 granted of 10- PendingTelomere-targeting Phosphatidyl-thio ConjugatesUSPTOApplication 18930974
- PendingDinucleotides And Their Use In Treating CancerUSPTOApplication 18352220
- PendingTumor Redox-activated 6-THIOPURINE Containing Dimer CompoundsUSPTOApplication PCTUS2024031754
Show all 10 patent records
- Telomere-targeting Phosphatidyl-thio ConjugatesMay 1, 2025 · Application 18930974Pending
- Dinucleotides And Their Use In Treating CancerApr 11, 2024 · Application 18352220Pending
- Tumor Redox-activated 6-THIOPURINE Containing Dimer CompoundsApplication PCTUS2024031754Pending
- Telomere-targeting Phosphatidyl-thio ConjugatesApplication 63546242Pending
- Dinucleotides And Their Use In Treating CancerApplication PCTUS2023070177Pending
- Tumor Redox-activated 6-THIOPURINE Containing Dimer CompoundsApplication 63469782Pending
- Dinucleotides And Their Use In Treating CancerApplication 63388688Pending
- Telomere-targeting Phosphatidyl-thio ConjugatesApplication PCTUS2024053473Pending
- Tumor Redox-activated 6-THIOPURINE Containing Dimer CompoundsApplication 19132345Pending
- Treatment Of Non-small Cell Lung Cancer With 6-THIO-DG And CemiplimabApplication PCTUS2024052463Pending
Related companies, and why
- THERMALIN DIABETES, LLCSimilar federal contract value in Biotech · null in contracts
- CYTODEL, INC.Similar federal contract value in Biotech · null in contracts
- ASYLIA THERAPEUTICS, INC.Similar federal contract value in Biotech · null in contracts
- Akeso Therapeutics IncSimilar federal contract value in Biotech · null in contracts
- Nistron, L.L.C.Similar federal contract value in Biotech · null in contracts
- StabiLux Biosciences, IncSimilar federal contract value in Biotech · null in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .